Status:

COMPLETED

Exploratory Study of Circadian Relationships Between Social Behavior, Blood Pressure and Metabolomics

Lead Sponsor:

University of Pennsylvania

Collaborating Sponsors:

Ginger.io

Conditions:

Healthy

Eligibility:

All Genders

25-35 years

Brief Summary

As citizens of the information age, humans leave digital traces of behavior in their communication and movement patterns through our cell phone. The Global Positioning System (GPS) technology tracks t...

Detailed Description

Cell phones with internet access (so-called smartphones) represent a rich source for user activity data. Each time one places a call, sends a text message, or uses an app, a data trace is being produc...

Eligibility Criteria

Inclusion

  • Volunteers must be in good health as based on medical history, physical examination, vital signs, and laboratory tests as deemed by PI;
  • Volunteers are capable of giving informed consent;
  • 25-35 years of age;
  • Own a cell phone with internet access (smartphone with Android operating system only at this point) which installs the social sensing application ginger.io;
  • Non-smoking;
  • Male subjects only if feasible during recruitment; and
  • In case female volunteers are invited to enroll: non-pregnant, female subjects must consent to a urine pregnancy test.

Exclusion

  • Recent travel across time zones (within the past month);
  • Planned travel across time zones during the planned study activities;
  • Volunteers with irregular work hours, e.g. night shifts.
  • Use of illicit drugs;
  • Subjects, who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of ≥ one pint within 8 weeks prior to screening.
  • Subjects with any abnormal laboratory value or physical finding that according to the investigator may interfere with interpretation of the study results, be indicative of an underlying disease state, or compromise the safety of a potential subject.

Key Trial Info

Start Date :

September 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2017

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT02249793

Start Date

September 1 2014

End Date

December 1 2017

Last Update

January 18 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104